Đang chuẩn bị liên kết để tải về tài liệu:
Quality of life and pain in patients with metastatic bone disease from solid tumors treated with bone-targeted agents – a real-world cross-sectional study from Switzerland (SAKK 95/16)

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

Bone-targeted agents (BTAs) are widely used in the management of patients with bone metastases from solid tumors. Knowledge of the impact of their routine care use on patient-reported pain and bone painrelated quality of life (QoL) is limited. |

TÀI LIỆU LIÊN QUAN

What factors are associated with health‐ related quality of life among patients with chronic musculoskeletal pain? A cross‐ sectional study in primary health care

Quality of life and pain in patients with metastatic bone disease from solid tumors treated with bone-targeted agents – a real-world cross-sectional study from Switzerland (SAKK 95/16)

The impact of depression among chronic low back pain patients in Japan

Effectiveness and tolerability of transdermal buprenorphine patches: A multicenter, prospective, open-label study in Asian patients with moderate to severe chronic musculoskeletal pain

Relationship between time elapsed since completion of radiotherapy and quality of life of patients with breast cancer

Influence of pain severity on the quality of life in patients with head and neck cancer before antineoplastic therapy

Báo cáo khoa hoc:" Influence of an outpatient multidisciplinary pain management program on the health-related quality of life and the physical fitness of chronic pain patients"

Cryoneurolysis for the management of chronic pain in patients with knee osteoarthritis; a double-blinded randomized controlled sham trial

Physical activity and health-related quality of life in chronic low back pain patients: A cross-sectional study

Effectiveness of three treatment strategies on occupational limitations and quality of life for patients with non-specific chronic low back pain: Is a multidisciplinary approach the key feature to success: Study protocol for a randomized controlled trial